Clinical trial
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
NCT07284186
Study timeline
Study start (actual)2025-12-01Date precision: day
Registry last updated2026-06-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Esophageal Squamous Cell Carcinomaunresolved
Gastric Adenocarcinomaunresolved
Gastric Squamous Cell Carcinomaunresolved
Metastatic Solid Tumorunresolved
Non-Small Cell Lung Carcinomaunresolved
Esophageal Adenocarcinomaunresolved
SMARCA4 Mutationunresolved
Advanced Solid Tumorunresolved
Interventions
PLX-61639DRUG
Sponsors & collaborators
Plexium, Inc.lead sponsor
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1St LouisMissouri, United States1San AntonioTexas, United States1ClevelandOhio, United States1DurhamNorth Carolina, United States1OrangeCalifornia, United States1ScottsdaleArizona, United States1FairfaxVirginia, United States1DuarteCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07284186 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.